https://doi.org/10.4081/hls.2023.11379
Helicobacter Pylori infection and non-alcoholic fatty liver disease. Is there a relationship?
Submitted: 10 April 2023
Accepted: 12 June 2023
Published: 22 June 2023
Accepted: 12 June 2023
Abstract Views: 1578
PDF: 384
HTML: 17
HTML: 17
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The most prevalent infection that causes chronic gastritis, gastric ulcers, and gastric cancer is Helicobacter pylori infection. Recent research has implicated H. pylori in the pathogenesis of non-gastrointestinal diseases such as cardiovascular, autoimmune, and metabolic disorders. In addition, since H. pylori is believed to be implicated in insulin resistance, numerous studies have been conducted to determine the relationship between H. pylori infection and nonalcoholic fatty liver diseases (NAFLD), but the results have been contested. The purpose of this study is to determine the relationship between H. Pylori infection and nonalcoholic fatty liver diseases. One hundred patients were examined via urea breath test for the presence of H. pylori infection and vibration-controlled transient elastography for the diagnosis of non-alcoholic fatty liver disease. After adjusting for other variables, age, body mass index (BMI), and H. pylori infection were associated with elastography 248dB/m. Infection with H. pylori contributes to the development of NAFLD, and its eradication may influence prognosis.
Narayanan M, Reddy K, Marsicano E. Peptic ulcer disease and Helicobacter pylori infection. Mo Med 2018;115:219-24.
Waluga M, Kukla M, Zorniak M. From the stomach to other organs: Helicobacter pylori and the liver. World J Hepatol 2015;18:2136-46.
DOI: https://doi.org/10.4254/wjh.v7.i18.2136
Kim D, Kim WR. Non-obese. Clin Gastroenterol Hepatol 2017;15:474-85.
DOI: https://doi.org/10.1016/j.cgh.2016.08.028
Younossi Z, Anstee M, Marietti M. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2018;15:11-20.
DOI: https://doi.org/10.1038/nrgastro.2017.109
Anstee M, Targher G, Day P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 2013;10:330-44.
DOI: https://doi.org/10.1038/nrgastro.2013.41
Arab P, Arrrese M, Trauner M. Recent insight into pathogenesis of nonalcoholic fatty liver disease. Annu Rev Pathol 2018;13:321-50.
DOI: https://doi.org/10.1146/annurev-pathol-020117-043617
Berlanga A, Guiu-Jurado E, Porras A, Auguet T. Molecular pathways in non-alcoholic fatty liver disease. Clin.Exp. Gastroenterol 2014;7:221-39.
DOI: https://doi.org/10.2147/CEG.S62831
Basaranoglu M, Basaranoglu G, Senturk H. From fatty liver to fibrosis: a tale of "second hit." World J Gastroenterol 2013;19:1158-65.
DOI: https://doi.org/10.3748/wjg.v19.i8.1158
Takaki A, Kawai D, Yamamoto K. Multiple hits including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). Int J Mol Sci 2013;14:20704-28.
DOI: https://doi.org/10.3390/ijms141020704
Buzzetti E, Pinzani M, Tsochatzis A. The multiple- hit pathogenesis of non-alcoholic fatty liver (NAFLD). Metabolism 2016;65:1038-48.
DOI: https://doi.org/10.1016/j.metabol.2015.12.012
Khosravi Y, Seow S, Moyo A, et al. Helicobacter pylori infection can affect energy modulating hormones and body weight in germ free mice. Sci Rep 2015;5:8731.
DOI: https://doi.org/10.1038/srep08731
Sumida Y, Kanemasa K, Imai S, et al. Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease. J Gastroenterol 2016;50:996-1004.
DOI: https://doi.org/10.1007/s00535-015-1039-2
Doust J, Glasziou P. Monitoring in clinical biochemistry. Clin Biochem Rev 2013;34:85-92.
Sabbagh P, Mohammadnia-Afrouzi M, Javanian M, et al. Diagnostic methods for Helicobacter pylori infection: ideals, options, and limitations. Eur J Clin Microbiol Infect Dis 2019;38:55-66.
DOI: https://doi.org/10.1007/s10096-018-3414-4
Tapper EB, Loomba R. Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD. Nat Rev Gastroenterol Hepatol 2018;15:274-82.
DOI: https://doi.org/10.1038/nrgastro.2018.10
Allen A, Therneau T, Larson J, et al. Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: a 20 year- community study. Hepatology 2018;67:1726-36.
DOI: https://doi.org/10.1002/hep.29546
Alqahtani Schattenberg J. NAFLD in the Elderly. Clin Interv Aging 2021;16:1633-49.
DOI: https://doi.org/10.2147/CIA.S295524
Ballestri S, Nascimbeni F, Baldelli E, et al. NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk. Adv Ther 2017;34:1291-326.
DOI: https://doi.org/10.1007/s12325-017-0556-1
Hamaguchi M, Kojima T, Ohbora A. Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. World J Gastroenterol 2012;18:237-43.
DOI: https://doi.org/10.3748/wjg.v18.i3.237
Wang Z, Xu M, Hu Z. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index. Menopause 2015;22:667-73.
DOI: https://doi.org/10.1097/GME.0000000000000352
Polyzos S, Kountouras J, Mantzoros C. Adipose tissue, obesity and non-alcoholic fatty liver disease. Minerva Endocrinologica 2017;42:92-108.
DOI: https://doi.org/10.23736/S0391-1977.16.02563-3
Fan Wang J, Du J. Association between body mass index and fatty liver risk: A dose-response analysis. Sci Rep 2018;8:15273.
DOI: https://doi.org/10.1038/s41598-018-33419-6
Almobarak A, Barakat S, Kalifa M, et al. Non-alcoholic fatty liver disease (NAFLD) in a Sudanese population: what is the prevalence and risk factors. Arab J Gastroenterol 2014;15:12-5.
DOI: https://doi.org/10.1016/j.ajg.2014.01.008
Mato J, Alons C, Noureddin M, Lu SC. Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease. World J Gastroenterol 2019;25:3009-20.
DOI: https://doi.org/10.3748/wjg.v25.i24.3009
Kantartzis K, Stefan N. Cardiovascular disease in patients with non-alcoholic fatty liver disease. Ann Gastroenterol 2012;25:276.
DOI: https://doi.org/10.1016/S0084-3873(12)00316-1
Sookoian S, Castano C, Scian R, et al. Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbatins at the amino acid and Krebs cycle level. Am J Clin Nutr 2016;103:422-34.
DOI: https://doi.org/10.3945/ajcn.115.118695
Ma X, Liu S, Zhang J, et al. Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis. BMC Gastroenterol 2020;14:10.
DOI: https://doi.org/10.21203/rs.2.17842/v2
Santos C, de Brito B, da Silva F, et al. Helicobacter pylori infection: Beyond gastric manifestations. World J Gastroenterol 2020;26:4076-93.
DOI: https://doi.org/10.3748/wjg.v26.i28.4076
Polyzos A, Kountouras J, Paptheodorou A, et al. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. Metabolism 2013;62:121-6.
DOI: https://doi.org/10.1016/j.metabol.2012.06.007
Wei L, Guo Ding H. Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease: What should we expect from a meta-analysis? Medicine (Baltimore) 2021;100:e26706.
DOI: https://doi.org/10.1097/MD.0000000000026706
Liu R, Liu Q, He Y, et al. Association between helicobacter pylori infection and nonalcoholic fatty liver: A meta-analysis. Medicine (Baltimore) 2019;98:e17781.
DOI: https://doi.org/10.1097/MD.0000000000017781
Yan P, Yu B, Li M, Zhao W. Association between nonalcoholic fatty liver disease and Helicobacter pylori infection in Dali City, China. Saudi Med J 2021;42:735-41.
DOI: https://doi.org/10.15537/smj.2021.42.7.20210040
Liu Y, Li D, Li Y, Shuai P. Association between Helicobacter pylori infection and non-alcoholic fatty liver disease, hepatic adipose deposition and stiffness in Southwest China. Front Med (Lausanne) 2021;8:764472.
DOI: https://doi.org/10.3389/fmed.2021.764472
Jamali R, Mofid Vahedi Farzaneh R, Dowlatshahi S. The effect of helicobacter pylori eradication on liver fat content in subjects with non-alcoholic Fatty liver disease: a randomized open-label clinical trial. Hepatol 2013;13:e14679.
DOI: https://doi.org/10.5812/hepatmon.14679
How to Cite
Rashad Mostafa, N., Ali, A. A., Alkaphoury, M. G., & Marzo, R. R. (2023). <i>Helicobacter Pylori</i> infection and non-alcoholic fatty liver disease. Is there a relationship?. Healthcare in Low-Resource Settings, 11(s2). https://doi.org/10.4081/hls.2023.11379
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.